These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 9351546)

  • 1. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA; Gao X; Davis M; Hall M; Holzbeierlein J; Tawfik O
    J Am Coll Surg; 2005 Oct; 201(4):565-70. PubMed ID: 16183495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
    Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
    Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma.
    Pich A; Margaria E; Chiusa L; Ponti R; Geuna M
    Hum Pathol; 1996 Jul; 27(7):676-82. PubMed ID: 8698311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survival.
    Pinto AE; Monteiro P; Silva G; Ayres JV; Soares J
    Int J Biol Markers; 2005; 20(4):249-56. PubMed ID: 16398407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
    Rioux-Leclercq N; Epstein JI; Bansard JY; Turlin B; Patard JJ; Manunta A; Chan T; Ramee MP; Lobel B; Moulinoux JP
    Hum Pathol; 2001 Nov; 32(11):1209-15. PubMed ID: 11727260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study.
    Leonardi E; Dalla Palma P; Reich A; Caffo O; Luciani L
    Anal Cell Pathol; 2000; 21(1):21-33. PubMed ID: 11254222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas.
    Pepe S; Ruggiero A; D'Acquisto M; De Laurentiis M; De Placido S; Sandomenico C; Staibano S; De Rosa G; Lucariello A; D'Armiento M; Bianco AR
    Cancer; 2000 Sep; 89(5):1065-75. PubMed ID: 10964337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.
    Borre M; Stausbol-Gron B; Overgaard J
    J Urol; 2000 Sep; 164(3 Pt 1):716-21. PubMed ID: 10953132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
    Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer.
    Shyr YM; Su CH; Li AF; Wu CW; Lui WY
    Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.
    Shyr YM; Su CH; Wu LH; Li AF; Chiu JH; Wu CW; Lui WY
    Ann Surg; 1999 Apr; 229(4):523-7. PubMed ID: 10203085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma.
    Hofmockel G; Tsatalpas P; Müller H; Dämmrich J; Poot M; Maurer-Schultze B; Müller-Hermelink HK; Frohmüller HG; Bassukas ID
    Cancer; 1995 Jul; 76(2):296-306. PubMed ID: 8625106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of proliferative activity, DNA-ploidy, p53 and Ki-ras point mutations in colorectal liver metastases.
    Russo A; Migliavacca M; Bazan V; Maturi N; Morello V; Dardanoni G; Modica G; Bazan P; Albanese I; La Farina M; Tomasino RM
    Cell Prolif; 1998; 31(3-4):139-53. PubMed ID: 9853427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.
    Mandard AM; Denoux Y; Herlin P; Duigou F; van De Vijver MJ; Clahsen PC; van Den Broek L; Sahmoud TM; Henry-Amar M; van De Velde CJ
    Cancer; 2000 Oct; 89(8):1748-57. PubMed ID: 11042570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S; Bui MM; Lu L
    Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
    Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
    Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis.
    Layfield LJ; Saria EA; Berchuck A; Dodge RK; Thompson JK; Conlon DH; Kerns BJ
    J Surg Oncol; 1997 Dec; 66(4):230-6; discussion 236-7. PubMed ID: 9425325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.